Evidence map›Paper›PMID 42861290›Full record

ArticlePublic health challenges2026

Developing a Comprehensive Model for Explaining Treatment Adherence Behaviour: Evidence From the International Beamer Consortium.

Francisco Lupiáñez-Villanueva, Damien S E Broekharst, Eline J Mertens, Claire Everitt, Aad R Liefveld, Giuseppe Fico, Sjaak Bloem

Abstract read
In one paragraph

Article in Public health challenges, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Francisco Lupiáñez-VillanuevaPredictBy Research and Consulting Barcelona Spain.ORCID https://orcid.org/0000-0001-5361-7678
Damien S E BroekharstCenter for Marketing & Supply Chain Management Nyenrode Business University Breukelen the Netherlands.ORCID https://orcid.org/0000-0002-9778-6243
Eline J MertensCenter for Marketing & Supply Chain Management Nyenrode Business University Breukelen the Netherlands.ORCID https://orcid.org/0000-0001-5174-0306
Claire EverittDevices Centre of Excellence, Pfizer Cambridge UK.
Aad R LiefveldLink2Trials Hilversum the Netherlands.ORCID https://orcid.org/0009-0005-8716-2823
Giuseppe FicoLife Supporting Technologies Research Group Universidad Politécnica de Madrid Madrid Spain.
Sjaak BloemCenter for Marketing & Supply Chain Management Nyenrode Business University Breukelen the Netherlands.ORCID https://orcid.org/0000-0001-6388-9423

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Optimizing treatment adherence behaviour has become a focus in healthcare, as improved adherence enhances clinical outcomes, patient experiences and health system sustainability. For this optimization endeavour scholars have posited diverse variables divided into two clusters. The first variable cluster emphasizes treatment priority, treatment concerns and health consciousness. The second variable cluster highlights acceptance, control and subjective health experience. Although some of these variables have been tested in isolation, few comprehensive models have been established. Therefore, this study aims at establishing a comprehensive model for explaining treatment adherence behaviour. Method: An online questionnaire was administered to 4081 participants from six different countries. This questionnaire covered sample characteristics as well as instruments measuring health consciousness, treatment priority, treatment concerns, acceptance, control, subjective health experiences, medication compliance, health behaviour and treatment adherence behaviour. Data were analysed using descriptive, reliability, validity and model statistics. Result: All concepts in the established model were measured reliably and showed sufficient validity. Most associations between concepts were stable and statistically significant across the overall and segmented models, except for those associating treatment concerns with adherence behaviour and control with subjective health experience in the previous month. The analysis shows that health consciousness is modestly to moderately positively associated with treatment adherence indirectly via 12 intermediary pathways, four of which were consistently significant, two were largely nonsignificant, and the remaining pathways exhibited mixed patterns. Between 22.6% and 38.5% of variance was explained by the models. Conclusion: This model offers valuable insights into treatment adherence behaviour yet remains open to further refinement and development, either by striving for greater parsimony or by embracing relational complexity through data-driven machine learning approaches.

Indexed as

acceptancecontrolhealth behaviourhealth consciousnessmedication compliancesubjective health experiencetreatment adherence behaviourtreatment concernstreatment priority

Identifiers

PMID42861290
PMCPMC13654311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.